Genetics Molecular Diagnostic Testing by eyeGENE: Analysis of Patients With Hereditary Retinal Dystrophy Phenotypes Involving Central Vision Loss Akhila Alapati,1 Kerry Goetz,2 John Suk,1 Mili Navani,1 Amani Al-Tarouti,3 Thiran Jayasundera,3 Santa J. Tumminia,4 Pauline Lee,1 and Radha Ayyagari1 1Shiley Eye Center, University of California-San Diego, La Jolla, California, United States 2Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States 3W. K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States 4Office of the Director, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States Correspondence: Radha Ayyagari, PURPOSE. To analyze the genetic test results of probands referred to eyeGENE with a diagnosis Shiley Eye Center, Jacobs Retina of hereditary maculopathy. Center,Room206,Universityof California-San Diego, 9415 Campus METHODS. Patients with Best macular dystrophy (BMD), Doyne honeycomb retinal dystrophy Point Drive, San Diego, CA 92093, (DHRD), Sorsby fundus dystrophy (SFD), or late-onset retinal degeneration (LORD) were USA; screened for mutations in BEST1, EFEMP1, TIMP3, and CTRP5, respectively. Patients with
[email protected]. pattern dystrophy (PD) were screened for mutations in PRPH2, BEST1, ELOVL4, CTRP5, and Submitted: March 14, 2014 ABCA4; patients with cone-rod dystrophy (CRD) were screened for mutations in CRX, Accepted: July 18, 2014 ABCA4, PRPH2, ELOVL4, and the c.2513G>A p.Arg838His variant in GUCY2D. Mutation analysis was performed by dideoxy sequencing. Impact of novel variants was evaluated using Citation: Alapati A, Goetz K, Suk J, et al. Molecular diagnostic testing by the computational tool PolyPhen.